Study demonstrated that selectively reducing myeloid-biased hematopoietic stem cells (my-HSCs) in aged mice rejuvenated the immune system, enhanced lymphopoiesis, reduced inflammation, and improved responses to viral infection, highlighting a potential strategy for countering age-related immune decline.
International Experts Highlight Demand for Diagnostic Innovations as PenKid’s Research and Real-World Data Fuels Quest for Improved RRT Liberation Tools – Biotech Investments
Issuer: SphingoTec GmbH / Key word(s): Research Update/Conference 06.09.2023 / 10:00 CET/CEST The issuer is solely responsible for the content of this announcement. International experts